Skip to content

The effect of salacia-derived salacinol on the postprandial hyperglycemia suppression - A systematic review.

The effect of salacia-derived salacinol on the postprandial hyperglycemia suppression - A systematic review. - A systematic review of salacia-derived salacinol.

Status
Active, not recruiting
Phases
Unknown
Study type
Unknown
Source
JPRN
Registry ID
JPRN-UMIN000033045
Enrollment
10
Registered
2018-10-01
Start date
2018-06-19
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy adult volunteers with a fasting blood glucose level in the normal range or the boundary range (less than 126 mg/dL).

Interventions

None listed

Sponsors

Association for Salacia Promotion
Lead Sponsor
Review team Mr. Kenji Ikeda, Fujifilm Corporation Dr. Yuriko Oda, Fujifilm Corporation Dr.. Eriko Kishino, Ensuikou Sugar Refining Co. Ltd. Research Collaborator Professor Horoharu Kamioka, Tokyo University of Agriculuture Dr. Takahiro Yoshizaki, Toyo University Ms. Mari Makishi, Toho University
Collaborator

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Systematic literature search using scientific databases and registered databases for clinical trials and systematic review will be performed. Key inclusion criteria as follows: Participants: Healthy adult volunteers with a fasting blood glucose level in the normal range or the boundary range (less than 126 mg/dL). Intervention: Intake the foods containing salacia-derived salacinol more than 0.02 mg/meal. Comparison: Intake the foods not containing salacia-derived salacinol. Outcome: The suppression effects of postprandial hyperglycemia (see above outcome column) Study design: Adopt randomized, quasi-randomized and non-randomized (parallel group or cross over) comparison test.

Exclusion criteria

Exclusion criteria: The literature which does not meet the key inclusion criteria will be excluded. Intervention tests without a placebo intake group are excluded.

Design outcomes

Primary

MeasureTime frame
The primary outcome is the suppression effect on the postprandial hyperglycemia (ref1). Specifically, it is taken as the blood glucose level after ingestion of carbohydrate or a meal containing carbohydrate. (ref1) Since the fluctuation of blood glucose level after meals varies depending on the types or contents of carbohydrates loaded, such as a drink containing sucrose or a steamed rice, the primary outcome will be evaluated comprehensively using the Cmax and/or the area under the curve (AUC) of postprandial blood glucose level.

Countries

Japan

Contacts

Public ContactYoshiki Sakaino

Association for Salacia Promotion Office

yoshiki.sakaino@fujifilm.com03-6418-9130

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026